Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

30P - Molecular Analysis of Bone Sarcomas By Cytogenetic studies on Fine Needle Aspiration Samples

Date

15 Oct 2022

Session

Poster display session

Presenters

Anchal Mishra

Citation

Annals of Oncology (2022) 33 (suppl_8): S1383-S1430. 10.1016/annonc/annonc1095

Authors

A.N. Mishra1, S.M. Mishra2

Author affiliations

  • 1 Gandhi Medical College, Bhopal/IN
  • 2 Grind and Bath PVT ltd, Gurgaon/IN

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 30P

Background

Generally tissue samples from histopathology or open biopsy are used for cytogenetic analysis and only few studies have used tissue samples from Fine Needle aspiration for chromosomal analysis. To start neoadjuvant chemotherapy in bone sarcoma patients, we need final diagnosis. Open biopsy has its own disadvantages. FNAC and cytological examination can give valuable information about the tumor. Apart from immunocytochemistry and electron microscopic examination of aspirated tissue, chromosomal analysis has also become a tool in diagnosing bone sarcoma.

Methods

During the period of six years in our hospital from 2016 to 2022, we cytogenetically analyzed FNACs from 11 primary bone sarcomas (4 osteosarcomas and 7 Ewing sarcomas). Out of them one of the osteosarcomas showed abnormal, complex karyotypes seen in most highly-malignant osteosarcomas and Four Ewing's sarcoma aspirates displayed abnormal karyotypes; two of these had the characteristic 11;22 translocation, and in one of these cases molecular genetic analysis revealed the hybrid EWS/FLI1 transcript.

Results

Chromosomal analysis of FNACs from suspected osteosarcoma didn’t provide much information, few cases showed high-grade malignancy. But in Ewing's sarcomas, these were of great value in making the diagnosis. 11;22 translocation finding on chromosomal analysis was diagnostic and strongly supported the cytologic diagnosis in six cases of Ewing's sarcoma. Tissues obtained by FNAC was sufficient for cytologic, cytogenetic, and molecular genetic analysis in two tumors. Molecular genetic analysis in one tumor showed the classical EWS/FLI1 transcript in Ewing's sarcoma.

Conclusions

FNAC and cytological examination is of limited value in patients with osteosarcoma and cannot make precise diagnosis but they can give reliable information and support the diagnosis in cases of Ewing's Sarcomas and help in starting multimodality treatment for bone sarcoma patients at the earliest.

Clinical trial identification

CMCH1622.

Legal entity responsible for the study

CMCH.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.